Ethris Competitors and Similar CompaniesClear all

Ethris's competitors and similar companies include Ocugen and ProQR Therapeutics.

	Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.	Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases	ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date	Founding Date 2009	Founding Date 2013	Founding Date 2012
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations Planegg, DE HQ	Locations Malvern, US HQ	Locations Leiden, NL HQ Cambridge, US
Employees	Employees 504% decrease	Employees 84425% increase	Employees 166
Valuation ($)	Valuation ($) N/A	Valuation ($) 292.1 m	Valuation ($) 281.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $4.4m (FY, 2025)	Revenue (est.) €15.9m (FY, 2025)
Net income	Net income N/A	Net income ($67.8m) (FY, 2025)	Net income (€42.2m) (FY, 2025)